| Veröffentlichte Version Download ( PDF | 2MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
Laub, Otto, Leipold, Georg, Toncheva, Antoaneta A.
, Peterhoff, David, Einhauser, Sebastian
, Neckermann, Patrick, Borchers, Natascha S., Santos-Valente, Elisangela, Kheiroddin, Parastoo, Buntrock-Döpke, Heike, Laub, Sarah, Schöberl, Patricia, Schweiger-Kabesch, Andrea, Ewald, Dominik, Horn, Michael, Niggel, Jakob, Ambrosch, Andreas, Überla, Klaus, Gerling, Stephan, Brandstetter, Susanne, Wagner, Ralf und Kabesch, Michael
(2021)
Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children.
Frontiers in Pediatrics 2021 (9), S. 1-9.
Veröffentlichungsdatum dieses Volltextes: 26 Okt 2021 14:29
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.49374
Zusammenfassung
Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in ...
Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to better identify children who are immune against SARS-CoV-2 due to a previous infection and to better understand COVID-19 related immune reactions in children. Methods: In a cross-sectional design, children aged 1-17 were recruited through primary care pediatricians for the study (a) randomly, if they had an appointment for a regular health check-up or (b) if parents and children volunteered and actively wanted to participate in the study. Symptoms were recorded and two antibody tests were performed in parallel directed against S (in house test) and N (Roche Elecsys) viral proteins. In children with antibody response in either test, neutralization activity was determined. Results: We identified antibodies against SARS-CoV-2 in 162 of 2,832 eligible children (5.7%) between end of May and end of July 2020 in three, in part strongly affected regions of Bavaria in the first wave of the pandemic. Approximately 60% of antibody positive children (n = 97) showed high levels (>97th percentile) of antibodies against N-protein, and for the S-protein, similar results were found. Sufficient neutralizing activity was detected for only 135 antibody positive children (86%), irrespective of age and sex. Initial COVID-19 symptoms were unspecific in children except for the loss of smell and taste and unrelated to antibody responses or neutralization capacity. Approximately 30% of PCR positive children did not show seroconversion in our small subsample in which PCR tests were performed. Conclusions: Symptoms of SARS-CoV-2 infections are unspecific in children and antibody responses show a dichotomous structure with strong responses in many and no detectable antibodies in PCR positive children and missing neutralization activity in a relevant proportion of the young population.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Frontiers in Pediatrics | ||||
| Verlag: | Frontiers | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | LAUSANNE | ||||
| Band: | 2021 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 9 | ||||
| Seitenbereich: | S. 1-9 | ||||
| Datum | 4 Oktober 2021 | ||||
| Institutionen | Medizin > Lehrstuhl für Kinder- und Jugendmedizin Medizin > Lehrstuhl für Medizinische Mikrobiologie und Hygiene | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | ; antibody; neutralizing; COVID-19; SARS-CoV-2; children | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-493748 | ||||
| Dokumenten-ID | 49374 |
Downloadstatistik
Downloadstatistik